BMO Capital Markets raised the price target for the Exelixis Inc. (NASDAQ:EXEL) stock to ‘an Outperform’. The rating was released on June 24, 2023, according to finviz. The research report from Jefferies has resumed the stock to Buy, with a price target set at $28. The stock was initiated by Jefferies, who disclosed in a research note on October 07, 2021, to Buy and set the price objective to $28. In their research brief published June 06, 2021, H.C. Wainwright analysts reiterated the Exelixis Inc.